semaglutide mrna Frontiers PDB-101: Diabetes Mellitus: Diabetes Mellitus:

What the evidence actually suggests The strongest clinical evidence supports the idea that GLP-1 medications can improve inflammatory markers in many patients, particularly those with obesity, type 2 diabetes, fatty liver disease, and cardiovascular risk

Hello lemon gals

Research indicates that people on GLP-1 medications need 0.8-1.2 grams of protein per kilogram of body weight for maintenance, and up to 2.0 grams per kilogram during active weight loss to preserve muscle and support hair health

This makes GHK-Cu the outlier: the one compound of the three with meaningful clinical grounding, albeit primarily for skin and scar outcomes rather than deep surgical repair